National Association of Home Builders CEO Jerry Howard joins Zack Guzman to break down the latest developments in the housing market, as mortgage rates fall to a historic low. …read more […]
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 20.55% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors […] …read more […]
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 20.55% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors […] …read more […]
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 20.55% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors […] …read more […]
President Donald Trump says the next coronavirus relief bill in Congress must include payroll tax cuts. Yahoo Finance’s On the Move panel discusses how that would impact workers. …read more […]
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will… …read more […]
Vaccine-maker Novavax (NVAX) is a $6.5 billion company with only $18 million in trailing sales and no profits whatsoever — but “thanks” to the novel coronavirus, that could soon change. Indeed, in one analyst’s view, as little as a year from now, vaccinating patients against COVID-19 could turn out to be a billion-dollar business for Novavax — or more.But first, the bad news.In a note published Thursday, H.C. Wainwright analyst Vernon Bernardino cites “mathematical models we reviewed online” to argue that contrary to what optimists have been saying, “herd immunity” to infection with coronavirus may not be a viable option …read more […]
More Wall Street analysts are scrambling to keep up with Tesla’s incredible stock rally. …read more […]
The most you can lose on any stock (assuming you don’t use leverage) is 100% of your money. But on a lighter note, a… …read more […]
WAKEFIELD, Mass., July 17, 2020 /CNW/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, and GR Companies, Inc. (“Grassroots”), jointly announced today that Grassroots’s shareholders have approved the proposed Curaleaf acquisition of Grassroots. Over 87% of shareholder returned proxies approving the transaction at the July 16 shareholder meeting, resulting in unanimous approval in accordance with provisions of the Grassroots shareholders agreement. …read more […]
The United States and India signed a preliminary agreement on Friday on cooperating on emergency crude oil reserves, including the possibility of India storing oil in the U.S. emergency stockpile, officials said. U.S. Energy Secretary Dan Brouillette told reporters in a teleconference with India Oil Minister Dharmendra Pradhan, that officials will discuss details of the emergency reserves in the next months. …read more […]
As a general rule, when you hear about a tiny biotech “partnering” with a Big Pharma giant to market a drug, it’s the smaller company that’s doing all the work — and the larger company that’s providing the marketing heft (and the money to market the drug). But this news is a bit different. In fact, it’s the exact opposite of what you’d ordinarily expect.Nabriva Therapeutics (NBRV), a microcap biotech based in Dublin, Ireland, announced Thursday that it will partner up with American Big Pharma giant Merck (MRK) to market Merck’s “SIVEXTRO” antibiotic for treating acute bacterial skin and skin …read more […]
Getting rich doesn’t happen overnight… Well, unless you hit the lottery. But for most, it takes years of determination and a solid plan to get there. And one of the most overlooked game plans is making passive income investments.
There are lots of passive income investment strategies out there. But they all boil down to the simple idea of putting your assets to work.
For instance, let’s say you’ve got a fancy car that’s mostly collecting dust. It should be worth more money in the future, but in the meantime, it’s not really being used.
If this sounds familiar, there are website like …read more […]
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […] …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
